Literature DB >> 28165227

Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.

Kimberly D Barnash1, Juliana The2, Jacqueline L Norris-Drouin1, Stephanie H Cholensky1, Beau M Worley1, Fengling Li2, Jacob I Stuckey1, Peter J Brown2, Masoud Vedadi2, Cheryl H Arrowsmith2,3, Stephen V Frye1, Lindsey I James1.   

Abstract

The function of EED within polycomb repressive complex 2 (PRC2) is mediated by a complex network of protein-protein interactions. Allosteric activation of PRC2 by binding of methylated proteins to the embryonic ectoderm development (EED) aromatic cage is essential for full catalytic activity, but details of this regulation are not fully understood. EED's recognition of the product of PRC2 activity, histone H3 lysine 27 trimethylation (H3K27me3), stimulates PRC2 methyltransferase activity at adjacent nucleosomes leading to H3K27me3 propagation and, ultimately, gene repression. By coupling combinatorial chemistry and structure-based design, we optimized a low-affinity methylated jumonji, AT-rich interactive domain 2 (Jarid2) peptide to a smaller, more potent peptidomimetic ligand (Kd = 1.14 ± 0.14 μM) of the aromatic cage of EED. Our strategy illustrates the effectiveness of applying combinatorial chemistry to achieve both ligand potency and property optimization. Furthermore, the resulting ligands, UNC5114 and UNC5115, demonstrate that targeted disruption of EED's reader function can lead to allosteric inhibition of PRC2 catalytic activity.

Entities:  

Keywords:  methyllysine; one-bead-one-compound; peptidomimetic; polycomb

Mesh:

Substances:

Year:  2017        PMID: 28165227      PMCID: PMC5376495          DOI: 10.1021/acscombsci.6b00174

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  37 in total

1.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

2.  Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing.

Authors:  Kimberly D Barnash; Kelsey N Lamb; Jacob I Stuckey; Jacqueline L Norris; Stephanie H Cholensky; Dmitri B Kireev; Stephen V Frye; Lindsey I James
Journal:  ACS Chem Biol       Date:  2016-07-14       Impact factor: 5.100

3.  Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2.

Authors:  Lianying Jiao; Xin Liu
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

4.  Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.

Authors:  Natalia Milosevich; Michael C Gignac; James McFarlane; Chakravarthi Simhadri; Shanti Horvath; Kevin D Daze; Caitlin S Croft; Aman Dheri; Taylor T H Quon; Sarah F Douglas; Jeremy E Wulff; Irina Paci; Fraser Hof
Journal:  ACS Med Chem Lett       Date:  2015-12-07       Impact factor: 4.345

5.  An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

Authors:  Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin
Journal:  ACS Chem Biol       Date:  2013-04-24       Impact factor: 5.100

Review 6.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

Review 7.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

8.  Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.

Authors:  Serena Sanulli; Neil Justin; Aurélie Teissandier; Katia Ancelin; Manuela Portoso; Matthieu Caron; Audrey Michaud; Berangère Lombard; Simao T da Rocha; John Offer; Damarys Loew; Nicolas Servant; Michel Wassef; Fabienne Burlina; Steve J Gamblin; Edith Heard; Raphaël Margueron
Journal:  Mol Cell       Date:  2015-01-22       Impact factor: 17.970

9.  Role of the polycomb protein EED in the propagation of repressive histone marks.

Authors:  Raphael Margueron; Neil Justin; Katsuhito Ohno; Miriam L Sharpe; Jinsook Son; William J Drury; Philipp Voigt; Stephen R Martin; William R Taylor; Valeria De Marco; Vincenzo Pirrotta; Danny Reinberg; Steven J Gamblin
Journal:  Nature       Date:  2009-09-20       Impact factor: 49.962

10.  Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.

Authors:  Alexei Brooun; Ketan S Gajiwala; Ya-Li Deng; Wei Liu; Ben Bolaños; Patrick Bingham; You-Ai He; Wade Diehl; Nicole Grable; Pei-Pei Kung; Scott Sutton; Karen A Maegley; Xiu Yu; Al E Stewart
Journal:  Nat Commun       Date:  2016-04-28       Impact factor: 14.919

View more
  15 in total

Review 1.  Recent progress in developing selective inhibitors of protein methyltransferases.

Authors:  H Ümit Kaniskan; Jian Jin
Journal:  Curr Opin Chem Biol       Date:  2017-06-26       Impact factor: 8.822

Review 2.  Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.

Authors:  Nilesh Zaware; Ming-Ming Zhou
Journal:  Curr Opin Chem Biol       Date:  2017-07-06       Impact factor: 8.822

3.  Systematic Variation of Both the Aromatic Cage and Dialkyllysine via GCE-SAR Reveal Mechanistic Insights in CBX5 Reader Protein Binding.

Authors:  Kelsey M Kean; Stefanie A Baril; Kelsey N Lamb; Sarah N Dishman; Joseph W Treacy; Kendall N Houk; Eric M Brustad; Lindsey I James; Marcey L Waters
Journal:  J Med Chem       Date:  2022-01-11       Impact factor: 7.446

4.  A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2's Association with the HUSH Complex.

Authors:  Jarod M Waybright; Sarah E Clinkscales; Kimberly D Barnash; Gabrielle R Budziszewski; Justin M Rectenwald; Anna M Chiarella; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Kenneth H Pearce; Laura E Herring; Robert K McGinty; Nathaniel A Hathaway; Lindsey I James
Journal:  ACS Chem Biol       Date:  2021-08-20       Impact factor: 4.634

Review 5.  RNA-modifying proteins as anticancer drug targets.

Authors:  P Ann Boriack-Sjodin; Scott Ribich; Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2018-05-18       Impact factor: 84.694

6.  Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader.

Authors:  Frances Potjewyd; Anne-Marie W Turner; Joshua Beri; Justin M Rectenwald; Jacqueline L Norris-Drouin; Stephanie H Cholensky; David M Margolis; Kenneth H Pearce; Laura E Herring; Lindsey I James
Journal:  Cell Chem Biol       Date:  2019-12-09       Impact factor: 8.116

7.  Getting a handle on chemical probes of chomatin readers.

Authors:  Jarod M Waybright; Lindsey I James
Journal:  Future Med Chem       Date:  2020-01-10       Impact factor: 3.808

8.  Identification of novel EED-EZH2 PPI inhibitors using an in silico fragment mapping method.

Authors:  Kensuke Misawa; Noriyuki Yamaotsu; Shuichi Hirono
Journal:  J Comput Aided Mol Des       Date:  2021-02-26       Impact factor: 3.686

9.  Discovery of an H3K36me3-Derived Peptidomimetic Ligand with Enhanced Affinity for Plant Homeodomain Finger Protein 1 (PHF1).

Authors:  Isabelle A Engelberg; Jiuyang Liu; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Samantha A Ottavi; Stephen V Frye; Tatiana G Kutateladze; Lindsey I James
Journal:  J Med Chem       Date:  2021-05-17       Impact factor: 8.039

10.  Discovery of selective activators of PRC2 mutant EED-I363M.

Authors:  Junghyun L Suh; Kimberly D Barnash; Tigran M Abramyan; Fengling Li; Juliana The; Isabelle A Engelberg; Masoud Vedadi; Peter J Brown; Dmitri B Kireev; Cheryl H Arrowsmith; Lindsey I James; Stephen V Frye
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.